Following a cancelled deal with pharmaceutical company Roche, the Ofer-backed pharmaceutical company has raised the first tranche of a planned $56.3m series E round.

Juno Therapeutics completes initial public offering, with stocks soaring.

Maynooth University spin-out Profector Life Sciences enters into collaboration deal with Adapt Pharma.

Moderna Therapeutics, a US-based life sciences firm with ties to multiple universities, closes biggest biotech venture capital round in history at $450m.

Spark Therapeutics, a spin-out of Children's Hospital of Philadelphia, is developing gene therapy treatments for a rare blinding disorder and haemophilia.

Symic Biomedical, which is developing treatments for the non-cellular part of tissue, has raised $15m in a round featuring Eli Lilly and Mitsui.

Following a cancelled deal with pharmaceutical company Roche, the Ofer-backed pharmaceutical company has raised the first tranche of a planned $56.3m series E round.

AstraZeneca and Alexion both contributed to the $450m round, the biggest ever raised by a privately held drug developer.

Johnson & Johnson-backed oncology company Aduro has closed a series D round that will be used to advance its pipeline of drug candidates.